GlassScriptPhysician profile
Jason S Phillips
NPI 1558655431
$2,428.17
in general payments reported to CMS, 2019-2025
19 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $114 · 2021: $133 · 2022: $370 · 2023: $539 · 2024: $572 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,319.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $485.93 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $365.34 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $252.27 | 2023-2024 | Optimizer, Optimizer |
| Merck Sharp & Dohme LLC | $230.85 | 2021-2024 | Verquvo |
| Cvrx, INC. | $226.20 | 2023-2025 | Barostim Neo System |
| Lantheus Medical Imaging, INC. | $202.83 | 2019-2023 | Definity |
| Novartis Pharmaceuticals Corporation | $163.86 | 2020-2024 | |
| Amgen INC. | $158.50 | 2019-2024 | |
| Bridgebio Pharma, INC. | $93.08 | 2025 | Attruby |
| Boston Scientific Corporation | $49.80 | 2023 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $31.24 | 2022-2024 | Andexxa |
| Penumbra, INC. | $27.27 | 2024 | Indigo System |
| Daiichi Sankyo INC. | $26.34 | 2023 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.71 | 2025 | Jardiance |
| Angiodynamics, INC. | $21.96 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $21.89 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.30 | 2025 | |
| Biotronik INC. | $14.26 | 2022 | |
| Pfizer INC. | $13.54 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.